Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lafarrerr eyelash booster solution in women with idiopathic eyelash hypotrichosis
IRCT20190210042676N36Phase 2Completed
- Sponsor
- Fartak Lotus Chemical Industries
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bimatoprost in eyelash hypotrichosis, sponsored by Fartak Lotus Chemical Industries. Primary endpoints: Average change in eyelash length, Average change in eyelash thickness and 1 more. Started Dec 2024; status: completed.
02
Drugs
bimatoprost
03
Conditions
eyelash hypotrichosis
Beyond the preview
Go deeper on IRCT20190210042676N36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190210042676N36.